News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Daily News Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA L.A. McKeown July 11, 2023
News Conference News LINC 2023 PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD L.A. McKeown June 21, 2023
News Conference News ISET 2023 Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine Caitlin E. Cox January 26, 2023
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Daily News Worse Complications After PVI in Women Highlight Research Gaps L.A. McKeown August 16, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Conference News SCAI 2022 DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year L.A. McKeown May 23, 2022
News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News ACC 2021 SAFE-PAD Throws More Doubt on the Paclitaxel Mortality Signal L.A. McKeown May 16, 2021
News Daily News FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited L.A. McKeown January 12, 2021
News Daily News Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years L.A. McKeown September 17, 2020
News Daily News Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients L.A. McKeown August 21, 2020